3-(2-Chloro-ethyl)-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid [4-(2-amino-6-oxo-1,6-dihydro-pyrimidin-4-yl)-phenyl]-amide

ID: ALA284302

PubChem CID: 135531287

Max Phase: Preclinical

Molecular Formula: C17H14ClN9O3

Molecular Weight: 427.81

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Nc1nc(O)cc(-c2ccc(NC(=O)c3ncn4c(=O)n(CCCl)nnc34)cc2)n1

Standard InChI:  InChI=1S/C17H14ClN9O3/c18-5-6-27-17(30)26-8-20-13(14(26)24-25-27)15(29)21-10-3-1-9(2-4-10)11-7-12(28)23-16(19)22-11/h1-4,7-8H,5-6H2,(H,21,29)(H3,19,22,23,28)

Standard InChI Key:  AHKAPELWOPZKCD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    8.3167   -8.9000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8917   -8.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0917   -8.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2917   -7.4667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1417   -8.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1167   -7.4625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5417   -8.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0167   -9.2000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7792   -9.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5167   -6.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167   -4.6542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9167   -5.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3042   -5.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4667   -7.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5042   -5.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9125   -4.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6875   -8.1042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8917   -6.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5625   -9.5917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6167   -7.0292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1125   -3.6292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3667   -8.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1292   -5.6917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6917   -7.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6917   -6.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0917   -7.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2917   -6.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2917   -7.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6167   -8.8542    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.7917   -8.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  2  1  0
  5  1  1  0
  6  7  1  0
  7  5  1  0
  8  9  2  0
  9  1  1  0
 10 13  2  0
 11 16  1  0
 12 10  1  0
 13 18  1  0
 14  3  1  0
 15 13  1  0
 16 15  2  0
 17 14  1  0
 18 24  2  0
 19  5  2  0
 20 14  2  0
 21 16  1  0
 22  7  1  0
 23 12  1  0
 24 28  1  0
 25 27  2  0
 26 17  1  0
 27 26  1  0
 28 26  2  0
 29 30  1  0
 30 22  1  0
  3  8  1  0
  6  4  2  0
 25 18  1  0
 12 11  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA284302

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 427.81

Molecular Weight (Monoisotopic): 427.0908

AlogP: 0.52

#Rotatable Bonds: 5

Polar Surface Area: 166.21

Molecular Species: NEUTRAL

HBA: 11

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 12

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.12

CX Basic pKa: 2.73

CX LogP: 2.87

CX LogD: 2.87

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.38

Np Likeness Score: -1.73

References

1. Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, Denny BJ, Hartley JA..  (1995)  Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.,  38  (9): [PMID:7739008] [10.1021/jm00009a010]

Source

Source(1):

• Scientific Literature